Found: 8
Select item for more details and to access through your institution.
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac417
- By:
- Publication type:
- Article
Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 5, p. 774, doi. 10.1111/bjh.19037
- By:
- Publication type:
- Article
Current considerations in AYA Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 1, p. 72, doi. 10.1111/bjh.15640
- By:
- Publication type:
- Article
Monotypic plasmacytoid cells mimicking lymph node malignancy in the setting of COVID‐19 recovery.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. 666, doi. 10.1002/ajh.26408
- By:
- Publication type:
- Article
A multicenter, retrospective study of accelerated venetoclax ramp‐up in patients with relapsed/refractory chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E105, doi. 10.1002/ajh.26444
- By:
- Publication type:
- Article
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 185, doi. 10.1007/s00277-023-05475-0
- By:
- Publication type:
- Article
Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00109
- By:
- Publication type:
- Article
Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility.
- Published in:
- PLoS ONE, 2018, v. 13, n. 7, p. 1, doi. 10.1371/journal.pone.0199708
- By:
- Publication type:
- Article